Roche's Genentech launches new alliance aimed at achieving greater diversity in cancer trials

The U.S.-Swiss Big Pharma says its Advancing Inclusive Research Site Alliance will “advance the representation of diverse patient populations in the company’s oncology clinical trials, test recruitment and retention approaches, and establish best practices that can be leveraged across the industry to help achieve health equity for people with cancer,” according to a statement.